Upregulated protein expression level or enzymatic activity of GLUT1, HK2, PFK and PKM2 have been well documented in many human tumour types; in this light, the positron emission tomography (PET) is generally used to detect 18F‐fluorodeoxyglucose (18F‐FDG) uptake for cancer diagnosis in current clinical applications.6 This evidence concerns the gene SLC2A1 and neoplasm.